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Abstract 
 
Smoking during pregnancy is associated with low birth weight, premature delivery, neonatal 
morbidity and mortality. Nicotine is a major pathogenic compound of cigarette smoke, and 
binds to the nicotinic acetylcholine receptors (nAChR). To date, a total of 16 nAChR 
subunits have been identified in mammals including 9 α subunits, 4 β subunits and 1 δ, ε and 
γ subunit. The effect of smoking on these subunits in the human placenta has not yet been 
determined. Smoking is also associated with a reduced pre-eclampsia (PE) risk and its 
protective effects may occur via changes in nAChRs. 
 
Using western blot and immunohistochemistry (IHC) experimentation, this study 
investigated nine of the sixteen mammalian nAChR subunits (α2, α3, α4, α5, α7, α9, β1, β2 
and δ)  in the normal healthy human placenta, and compared protein expression of placentas 
from smokers (n=8), PE (n=8) and controls (n=8).  
 
The western blot data from this study showed that when compared to the control group, α9 
and δ were increased in both the smoker and PE groups. An increase in α7 was additionally 
seen in the PE group. Consistent with the western blot findings, a change in α7, α9 and δ 
subunit expression was observed at the cellular level using IHC, with additional, changes for 
α2 and β1 subunit. Specifically, for α7, the percentage of positive endothelial cells per 
villous was decreased in the smokers compared to both control and PE groups. For α9, a 
decrease was observed for the percentage of villi with positive cells in PE compared to 
controls, while a lower percentage of endothelial cells per villous in PE was evident 
compared to smokers. δ subunit expression was increased in the decidual cells of smokers 
compared to controls. For α2, the percentage of positive endothelial cells per villous and the 
villous cells was greater in the smoker group compared to the PE group. Finally, β1 was 
increased in villous and decidual cells of smokers compared to control and PE.  
 
Therefore, both exogenous regulation of placental nAChRs by cigarette smoke exposure and 
endogenous regulation, via ACh, are likely to alter nAChR subunit expression, and 
ultimately function, in the human placenta, impacting on infant outcomes. When comparing 
the nAChR subunits between smoking and PE groups, the possibility of a protective 
mechanism becomes an apparent possibility whereby alterations in certain subunits as a 
result of PE, can be counteracted by either exogenously agonizing or antagonizing the same 
subunits to reverse the effects. 
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Chapter 1 
Literature Review 
 
1.0 Introduction 
An estimated 20% of Australian women continue to smoke during pregnancy despite 
knowledge of the adverse effects smoking has during pregnancy (Australian Institute of 
Health and Welfare, 2006), including placenta previa (Oyelese & Smulian, 2006), abruption 
placenta (Oyelese & Ananth, 2006), ectopic pregnancy and preterm premature rupture of the 
membranes (Lee & Silver, 2001). Smoking also has detrimental effects on the foetus 
including low birth weight (Ventura et al., 2003; Fantuzzi et al., 2008), preterm birth (Kolas 
et al., 2000), foetal and neonatal death, and increases the risk of sudden infant death 
syndrome (SIDS) during infancy (Shah et al., 2006).  
 
Despite the adverse effects of smoking during normal pregnancy, a systematic review of 48 
epidemiology studies found that cigarette smoking is consistently associated with a reduced 
prevalence of pre-eclampsia (PE) (England & Zhang, 2007). PE is described as a pregnancy-
specific and multi-system disorder. PE affects approximately 3-5% of pregnancies 
worldwide (Sibai et al., 2005; Redman et al., 2005), while in Australia, it is reported to occur 
in 2-5 % of all pregnancies (Roberts et al., 2011). PE is characterised by the new onset of 
hypertension and proteinuria after 20 weeks of gestation (Mattar & Sibai, 1999; Sibai, 2008; 
Mutter & Karumanchi, 2008). The exact mechanism(s) involved in the development of PE 
are still not understood. However, it is apparent that the placenta plays a major role in the 
pathophysiology of PE, as its delivery resolves all clinical symptoms (Myatt & Webster, 
2009; Young et al., 2010; Andrus & Wolfson, 2010). The leading hypothesis postulates that 
PE occurs in two stages: 1) abnormal placentation, resulting in an ischaemic placenta 
secreting factors that lead to 2) the clinical manifestations of the syndrome (Roberts & 
Redman, 1993; Roberts & Cooper, 2001).  
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The mechanism(s) explaining how cigarette smoking is protective against PE remain 
unknown. Nicotine is the main pathogenic compound in cigarettes and it has been suggested 
that its protective effects are induced through the activation of nicotinic acetylcholine 
receptors (nAChRs) in the placenta (Sharentuya et al., 2012), of which there are 16 
mammalian subunits (α1-10; β1-4, δ, ε and γ subunits) (Fryer et al., 1998). Currently, there 
are only 2 studies concerning the expression of nAChR subunits in the placenta (Kwon et al., 
2007; Lips et al., 2005) however, they do not investigate how cigarette smoke affects nAChR 
subunit expression or how they are regulated by PE, with the exception of the α7 subunit 
(Kwon et al., 2007). 
 
Previously in our laboratory, we studied the mRNA expression of the 16 nAChR subunits in 
the placenta from normal, PE, and cigarette smoking women (David, 2012; Ghazavi, 2012). 
Our results showed that all 16 subunits are expressed at the mRNA level in the normal 
healthy placenta, and that in the placentas of smoking women the α9 subunit is increased and 
the δ subunit is decreased, while in the PE placenta, α2, α9 and β2 subunits are increased. 
Despite this novel data, understanding the changes in subunit expression at the protein level 
would provide a more precise indication of changes to receptor functionality, given it is at 
the protein level that functional receptors occur. Thus, through the application of western 
blot and immunohistochemistry, the studies described in the present thesis aimed to 
determine the effects of smoking and PE on nAChR subunit expression in the human 
placenta, at the protein level. We hypothesise that the same subunits with altered expression 
at the mRNA level will have altered expression at the protein level.  
 
1.1 Cigarette smoke and nicotine 
According to the American Lung Association (Abbott et al., 2012), cigarette smoke contains 
over 4800 identified chemicals. Besides nitrogen and oxygen, major components in cigarette 
smoke include carbon monoxide, methane and nicotine, with lesser but still substantial 
amounts of acetone, acetylene, formaldehyde, propane, hydrogen cyanide and toluene 
(Seaton et al., 1993).  
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While thousands of compounds are found in cigarette smoke, nicotine is the major 
psychoactive component (Rollema et al., 2007). Nicotine is a poisonous alkaloid with a short 
half-life of approximately two hours, and can rapidly perfuse through the human placenta 
due to a low molecular weight and high lipid solubility (Lambers et al., 1996).  
Cotinine is the major metabolite of nicotine. It is the preferred biological marker for 
measuring precise cigarette smoke exposure as it has a much longer half-life (15–20 hours) 
and provides serum concentrations that are 10-fold higher than nicotine (Zevin et al., 1998).  
 
1.1.2 Cigarette smoking during pregnancy 
Chronic exposure of the foetus to the effects of tobacco smoke is recognised as the most 
important preventable risk factor for a complicated pregnancy outcome in all developed, and 
an increasing number of developing, countries (Jauniaux et al., 2007). Despite this, it is 
estimated that one in five Australian women smoke during pregnancy (Australian Institute of 
Health & Welfare, 2006) and this is associated with several negative outcomes for both the 
mother and the foetus. For the mother, negative outcomes include an increased risk of 
ectopic pregnancy, abruptio placentae, placenta praevia and preterm prelabour rupture of 
membranes (Ananth et al., 1999). For the foetus, prematurity and intrauterine growth 
restriction (IUGR) are two major adverse consequences. Both of these result in decreased 
birth weight of the infant by an average of 170 to 250 g (Hardy & Mellits, 1972; Horta et al., 
1997). Lower infant birth weight is strongly associated with infant morbidity and mortality, 
including an increased risk of heart, breathing and brain abnormalities (Huang et al., 2007), 
and increased risk of Sudden Infant Death Syndrome (SIDS) (Adgent, 2004; Shah et al., 
2006).  
 
1.2 Pre-eclampsia (PE) 
1.2.1 Definition and characterization of PE 
Pre-eclampsia (PE) is a multi-system disorder, which is characterized by proteinuria 
developing after 20 weeks of gestation as well as hypertension. Specifically, in Australia the 
definition of hypertension constitutes systolic blood pressure >140 mmHg and diastolic 
blood pressure >90 mmHg (Douglas et al., 2001). Additional symptoms (summarized in 
Table 1.1) are associated for consideration of diagnosis within Australia. PE affects 2-5% of 
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pregnancies (Roberts et al., 2011) and causes substantial maternal and neonatal morbidity 
and mortality (Redman et al., 2005; Sibai et al., 2005).  
 
Table 1.1: Clinical symptoms associated with PE as additional considerations for 
diagnosis used in Australia  
System involvement Clinical symptoms 
Renal involvement Significant proteinuria – dipstick proteinuria 
subsequently confirmed by spot urine protein/creatinine 
ratio ≥ 30 mg/mmol. 
Serum or plasma creatinine > 90 µmol/L 
Oliguria 
Hematological involvement Thrombocytopenia 
Hemolysis 
Disseminated intravascular coagulation 
Liver involvement Raised serum transaminases 
Severe epigastric or right upper quadrant pain 
Neurological involvement Convulsions (eclampsia) 
Hypereflexia with sustained clonus 
Severe headache 
Persistent visual disturbances (photopsia, scotomata, 
cortical blindness, retinal vasospasm) 
Stroke 
Other Pulmonary edema 
Foetal growth restriction 
Placental abruption 
(Table derived from Douglas et al., 2001 
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1.2.2 Risk factors associated with PE 
There are a number of known prior risk factors for PE separated into pre-conception and 
pregnancy related, as summarized in Table 1.2. 
 
Table 1.2. Risk factors for pre-eclampsia 
(Table derived from Dekker, 1999) 
 
1.2.3 PE management and prophylaxis 
Serious morbidity associated with PE can occur from 20 weeks gestation to after delivery.  
PE onset before 32 weeks leads to the most severe outcome, and on average the interval 
between diagnosis and delivery is 14 days (0-62 days) with a substantial number of women 
delivering within 72 hours (Sibai et al., 1994). In fact, 15% of all preterm births are a 
consequence of PE. 
 
Pre-conception and/or 
chronic risk factors 
Partner-related 
risk factors 
Nullparity/primiparity/teenage 
pregnancy 
Limited sperm exposure, donor 
insemination, oocyte donation 
Partner who fathered a PE pregnancy in 
another woman 
 Non partner 
related risk 
factors 
History of previous PE 
Age, interval between pregnancies 
Family history 
 Presence of 
specific 
underlying 
disorders 
Chronic hypertension and renal disease, 
obesity, insulin resistance, low birth 
weight, gestational diabetes, type I 
diabetes mellitus, activated protein 
C resistance, protein S deficiency, 
antiphospholipid antibodies, 
hyperhomocysteinemia, sickle cell 
disease, sickle cell trait 
 Exogenous 
factors 
Stress, work-related psychosocial strain 
In utero diethylstilbestrol exposure  
Pregnancy- associated risk 
factors  
 Multiple pregnancy 
Structural congenital abnormalities 
Hydrops fetalis 
Chromosomal anomolies (trisomy 12, 
triploidy) 
Hydatidiform mole 
Urinary tract infection 
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About one third of the foetuses from women with severe PE suffer from IUGR (Shibata et 
al., 2008). Prenatal identification of IUGR is important as these foetuses are at increased risk 
of short term adverse outcomes such as: foetal distress, intrauterine demise, cerebral bleeding 
and seizures, respiratory distress, sepsis and infant death (Fang, 2005). Also, later in life 
babies born too small are at increased risk of type 2 diabetes, hypertension and attention 
deficit disorder (Bele et al., 2006).  
 
Currently, the only “cure” for PE is the delivery of the placenta (Myatt & Webster, 2009; 
Young et al., 2010; Andrus & Wolfson, 2010). Therefore, current management aims to lower 
high blood pressure through the use of antihypertensive agents. In Australia, the common 
antihypertensive medication administered includes labetalol, hydralazine and 
diazoxide (Xu et al., 2006). In severe cases of PE, the protocol to prevent seizures is the 
administration of magnesium sulfate. Aspirin has also been used as a prophylactic treatment. 
This drug potentially inhibits platelet production of thromboxane, a vasoconstrictor and 
stimulant of platelet aggregation. The overall aim of PE management is to prolong gestation 
to improve foetal prognosis although it is understood that this increases the risk of potential 
harm to the mother. 
 
1.3 The human placenta 
1.3.1 Anatomy 
The human placenta is the most important foetal accessory structure. It brings maternal and 
foetal circulations and tissues into close relationship (Figure 1.1). Morphologically, its origin 
is part foetal (the trophoblast) and part maternal (from a transformation of the uterine 
mucosa). The highly proliferative, migratory, and invasive extra-villous trophoblast cells of 
the placenta migrate and invade the uterus and its vasculature, to provide a vital link between 
the mother and the developing foetus (Spencer et al., 1994). It is therefore, ideally suited to 
perform life-sustaining functions such as the exchange of nutrients, respiratory gases and 
metabolic wastes, with the maternal supply. It also plays a central role in the maintenance of 
the immunologically privileged status of the foetus while allowing anchorage to the maternal 
uterine wall (Donnelly and Campling, 2011), and serves as a special endocrine organ by its 
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ability to elaborate a myriad of protein, peptide and steroid hormones (Vause and Saroya, 
2005). 
 
 
 
Figure 1.1. Diagram of the placental circulation. 
Maternal blood enters the placental circulation through the endometrial arteries, and 
circulates around the chorionic villi for the exchange to occur. The deoxygenated blood 
exits the placenta through the endometrial veins. From the foetal side, the foetal blood enters 
the placenta through the umbilical arteries, which branch out into the chorionic villi for the 
exchange to occur. The oxygenated foetal blood returns to the foetus through the umbilical 
vein. (Figure taken from Kumar et al., 2009). 
 
 
1.3.2 Histology and Microscopic features 
 
As described by Benirschke (1998), the trophoblast can be thought of as the working end of 
the placenta. It covers all villi and also surrounds the membranes, the chorion laeve. The 
trophoblast in turn, is surrounded by maternal blood and for this reason the human placenta 
is recognized as being haemochorial in type. Two principal types of trophoblast can be 
distinguished: cytotrophoblasts and unicellular extravillous trophoblast. The cytotrophoblast 
has proliferative ability sending nuclei and cytoplasm into the syncytium. The 
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cytotrophoblastic cells, existing as a single Langhans layer over the connective tissue of the 
villi, are known only to add cellular components to the syncytium. Little endocrine or 
synthetic activity has been ascribed to this tissue, but its continued reproduction relentlessly 
adds new cytoplasm, organelles, and nuclei to the syncytiotrophoblast (Benirschke, 1998). 
This syncytial sheet of contiguous cytoplasm, nearly 10 m2 in size, is known to regulate the 
exchange between mother and foetus, and is additionally responsible for placental hormone 
and enzyme production. Its surface provides the major haemal contact with the intervillous 
blood and possesses a plethora of microvilli for enhanced exchange. As the intervillous 
circulation is hampered occasionally by disease states (e.g. PE), there is less fluid transfer to 
the villous circulation; the consequence of this is foetal growth retardation. The villi also 
suffer this malnutrition and shrink, allowing the syncytial epithelium to buckle. They thus 
produce an excessive number of knots, the so-called Tenney-Parker change, named after the 
first description of this feature (Tenney and Parker, 1940) but now commonly referred to as 
syncitial knots (Huppertz et al., 1998) (Figure 1.2C).  
 
The other principal type of trophoblast is known as the unicellular extravillous trophoblast 
that occurs primarily beneath the chorionic plate and, as anchoring cell columns, at the site 
of placental villous attachment to the decidua basalis. Because of its initially disputed origin 
(maternal or foetal), the cells were originally called the X-cells (Scipiades and Burg, 1930). 
These cells are now recognized as being of foetal origin and were recently misnamed the 
intermediate trophoblast, although they are not a precursor to any other cell type. They 
produce various interesting substances whose physiological function in pregnancy is 
unknown including being the source of large quantities of major basic protein [MBP] 
(Wasmoen et al., 1985), a protein that is essentially similar to the eosinophilic granular 
protein of leukocytes (Benirschke, 1998). There is a remarkable increase of this toxic protein 
in the maternal blood during pregnancy, only to disappear immediately after delivery 
(Maddox et al., 1983). Likewise, much of the human placental lactogen (hPL) is produced by 
these X-cells for reasons that are also obscure, and the cells may be stained for cytokeratin. 
Slightly better understood now is their production of a variety of basement membrane 
proteins that impose as fibrinoid in the evolution of the placenta. They open the maternal 
blood vessels and alter their structure by replacing the muscular wall of spiral arterioles with 
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a stiff eosinophilic matrix. They also lay down some of the fibrinoid in the decidua basalis 
(Benirschke and Kaufmann, 1995).  
 
Hofbauer cells are also considered a microscopic component of the placenta. They are the 
macrophages within the villous stroma and chorio-amnionic membranes. Hofbauer cells are 
often more abundant in immature placentas. Naturally, these cells are often engaged in 
phagocytosis (e.g., meconium, hemosiderin) and originally derive from the mononuclear 
phagocyte system (Castellucci et al., 2000).  From the occasional hemosiderin content of 
Hofbauer cells, the occurrence of focal hemorrhage in certain villi can be determined, usually 
after congenital infection with cytomegalovirus, thrombosis and destruction of capillaries. 
The Hofbauer cells may well represent an important sentinel population that accumulates 
unwanted products during disturbed gestations. In the superficial membranes, Hofbauer-like 
macrophages are best known from their ability to ingest meconium pigment after its 
discharge into the amnionic sac.  
 
This thesis will focus its study on three particular cellular layers of the placenta being 1) 
endothelial cells, 2) villous cells and 3) decidual cells. These are discussed in detail below 
and are summarized in Table 1.3. 
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Figure 1.2. Histology of the human placenta. Histological images of the various cell layers 
of the human placenta including a) Membranes, b) Chorionic plate, c) Terminal villi and d) 
Basal plate.  
 
1.3.2.1 Endothelial trophoblast cells 
The endothelial trophoblast cells are embedded within the connective tissue of the maternal 
villous (Allaire et al., 2000; Zhou et al., 2002). EC constitute microvessels where 
angiogenesis occurs. Vascular endothelial growth factor (VEGF) is expressed in EC and is 
up-regulated under hypoxia, which is the principal inducer of angiogenesis (Nomura et al., 
1995, Yonekura et al., 1999). Endothelial cells express several angiostatic factors such as 
sFlt-1, soluble neuropilin-1, thrombospondin and endostatin (Wu et al., 2001, Li et al., 
2004). VEGF binds to sFlt-1, a potent anti-angiogenic factor, where it regulates various 
physiological processes in tissues including maintaining avascularity (Ambati et al., 2006), 
guiding vessel sprouting, and morphogenesis in developing blood vessels (Chappell et al., 
2009). Excess circulating sFlt-1 has been implicated in the aetiology of endothelial 
dysfunction, hypertension and proteinuria in PE (Maynard et al., 2003), and sFlt-1 over 
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expression has been reported to inhibit tumour growth and angiogenesis (Goldman et al., 
1998). Thus EC play an important role in vascular regulation and angiogenesis, both of 
which are essential for embryogenesis and blood vessel development. 
 
1.3.2.2Villous cells 
Foetal growth and development depends on a continuous nutrient supply from maternal 
blood (Battaglia et al., 1986, Morriss et al., 1988). In the human placenta the supply process 
includes uptake from maternal blood and transfer across the syncytiotrophoblast and 
cytotrophoblast layers, the underlying basal lamina, the foetal connective tissue space, and 
the foetal capillary endothelium. The placental syncytiotrophoblast is a continuous epithelial 
layer. It covers the maternal surface of the human placenta (Sideri et al., 1983., Williams et 
al., 1989) and forms by fusion and terminal differentiation of the underlying cytotrophoblast. 
The microvillous membrane of the syncytiotrophoblast is in contact with the maternal blood 
while the basal membrane faces the foetal circulation. For the purpose of this thesis, analysis 
of the villous cells will be for the combination of syncytio- and cyto- trophoblasts. Flux 
across the syncytiotrophoblast and its plasma membranes represent the rate-limiting steps in 
maternal-foetal transfer of most important nutrients. Most sites of known mechanisms of 
cellular transport are localized to the maternal- and foetal-facing plasma membrane surfaces 
of the syncytiotrophoblast (Sideri et al., 1983). Regulation of syncytiotrophoblast transport 
mechanisms is potentially of great importance in the control of foetal nutrient supply. 
Regulation of transport may be affected either by intrinsic mechanisms, in which substrate or 
cellular proteins interact with transporters, or by extracellular or circulating hormones or 
effectors (Kilberg et al., 1985) and their receptors in the trophoblast (Brunette et al., 1988). 
In addition to physiologic regulators, considerable evidence suggests that environmental 
substances such as ethanol, cannabinoids and nicotine can alter transport of various nutrients 
(Fisher et al., 1987).  
 
1.3.2.3 Decidual cells  
The endometrium undergoes a remarkable transformation and remodeling response to 
implantation of the blastocyst, collectively referred to as decidualisation. During this process, 
the spindle-shaped endometrial stromal fibroblasts are formed into large, secretory decidual 
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cells. Thus, the decidual cells are found embedded within the decidual connective tissue 
(Benirschke et al., 2012) (Figure 1.2D). Decidual and trophoblast cells are likely to provide 
the signaling system that coordinates the activities of the maternal compartment. Decidual 
cells are modified uterine endometrial stromal cells. The differentiation of decidual cells is 
one of the earliest uterine adaptations to pregnancy (DeFeo, 1967; Parr and Parr, 1989; 
Aplin, 2000). Decidual cell differentiation is exquisitely sensitive to the regulatory actions of 
progesterone, interleukin-11, and activators of cyclic AMP/protein kinase A (Tang et al., 
1994; Lydon et al., 1995; Brar et al., 1997; Dimitriadis et al., 2005; Brosens and Gellersen, 
2006). During gestation, decidual cells are located at the interface separating invading 
trophoblast cells from the maternal environment (Figure 1.2 A & D). A number of important 
functions have been attributed to decidua (Bell, 1983; Aplin, 2000; Brosens and Gellersen, 
2006): (1) a protective role in controlling trophoblast cell invasion; (2) a nutritive role for the 
developing embryo; (3) a role in preventing immunological rejection of genetically disparate 
embryonic/foetal tissues; and (4) an endocrine/paracrine role in controlling maternal 
adaptations required for the establishment and maintenance of pregnancy. Pregnancy is 
dependent upon decidual cell acquisition of each of these specialized functions. Disruptions 
in decidual cell development are not compatible with pregnancy (Lydon et al., 1995; Bilinski 
et al., 1998; Robb et al., 1998; Mantena et al., 2006). Progress in understanding specialized 
decidual cell functions has been limited. 
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Table 1.3. Function of the various cell types found in the human placenta. Namely the 
decidual cells, villous cells and endothelial cells. 
 
Cell Type Function Reference 
Decidual cells Contribute to regulation of 
vascular remodeling 
Nomura et al., 1995, 
Yonekura et al., 
1999 
Villous cells (encompassing 
syncytio- and cyto- 
trophoblasts) 
Facilitate oxygen and nutrient 
exchange 
Endocrine role which supports and 
regulates placental and foetal 
development and growth 
Sideri et al., 1983 
Endothelial cells Provide an intelligent 
semipermeable barrier for 
transcytosis and delivery of 
macromolecules such as hormones, 
growth factors, and 
immunoglobulins 
Alam et al., 2007 
 
 
1.3.3 Effect of cigarette smoking on the human placenta  
Most tobacco toxins have a low molecular weight and high water solubility, and therefore 
readily cross the placenta. In particular, nicotine and cotinine pass freely across the placenta 
to the foetus, which as a result is exposed to approximately 15% higher nicotine 
concentrations than its mother (Eskenazi et al., 1995). Many changes have been reported in 
the placentas of smoking mothers (a selection of these have been summarized in Table 1.4). 
Histologically, placenta samples from smoking mothers have increased apoptosis (Erel et al., 
2001; Jauniaux et al., 2007), reduced placental weight and atrophic placental villi compared 
to gestational age-matched non-smoking mothers (Naeye, 1987). The differences have 
mainly been observed in perivillous fibrin deposition and in the syncytiotrophoblast layer, 
which is the outermost foetal component of the placenta involved in nutrient exchange 
between mother and foetus (Naeye, 1987). Functionally, at twenty weeks of gestation, 
women who smoke exhibit significantly higher umbilical artery resistance, which is 
interpreted to be a surrogate measure for abnormal placental vascular formation as well as 
reduced estimated foetal weights (Kho et al., 2009). Other changes include calcification 
(Klesges et al., 1998), a reduction in the diameter of chorionic villi, and depression of active 
amino acid uptake (Sastry et al., 1991).  
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1.3.4 Effects of PE on the human placenta 
The etiology of PE remains unknown, however, a shallow cytotrophoblast invasion of 
maternal spiral arterioles (Figure 1.3), resulting in placental insufficiency is considered 
central to the pathogenesis (Redman et al., 2005). The oxidatively stressed placenta, releases 
factors into the maternal circulation, which induces a maternal systemic inflammatory 
response and generalized endothelial dysfunction that leads to the clinical signs of PE, 
including hypertension, glomerular endotheliosis, and proteinuria (Redman et al., 2005).  
 
The implication of this theory is that PE is mainly a disease of the maternal vascular 
endothelium (Roberts et al., 1998; Wang et al., 2007). Normal pregnancy is characterized by 
a mild systemic inflammatory response with evidence for an acute phase reaction and 
activation of multiple components of the inflammatory network (Borzychowski et al., 2006). 
As pregnancy advances, the systemic inflammatory response strengthens, peaking during the 
second half of pregnancy. In PE, this systemic inflammatory response is reported to be more 
intense than in normal pregnancy (Borzychowski et al., 2006). Although the precise 
mechanisms remain undetermined, endothelial cells and unknown circulating factors from 
placenta are considered to play a key role in this systemic inflammatory response (Redman et 
al., 2009). 
 
Morphological and pathological changes reported in the PE placenta include increased 
apoptosis and calcification and reduced amino acid uptake (summarised in Table 1.4). 
Modification in chorionic villi size seen in PE is not yet known to date. The rate of apoptosis 
is thought to be increased in PE as a result of placental oxidative stress, which is frequently, 
although not universally, increased in the condition (Hung et al., 2002). Other gross 
abnormalities also noted are placental infarcts, retroplacental haematoma and calcification 
(Sodhi et al., 1990). Furthermore, women with PE are reported to have a higher levels of 
ACh in their placenta (Murthy et al., 1977). However, ACh synthesis in advanced syncytial 
degeneration, such as PE, is significantly reduced suggesting that in the placenta, ACh 
synthesis reflects the state of the syncytiotrophoblast (Satyanarayana, 1986). Moreover, the 
output of ACh by the PE placenta is greatly reduced (Krishna et al., 1987; Murthy et al., 
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1985) including through the foetal vessels (King et al, 1991). Thus, it seems that although 
maternal surface ACh levels are increased in PE, the transport to the foetal circulation is 
reduced, which may affect amino acid transport, and could result in fetal intrauterine growth 
restriction (IUGR) (Brennecke et al., 1988) (Table 1.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. Normal placental development (top) and placental development in 
pre-eclampsia (bottom). The bottom figure shows the shallow invasion of the 
cytotrophoblasts, leading to the failure to complete vascular remodeling: vessels retain 
features of low capacitance and high resistance. Thus, resulting in the reduced blood flow 
to the placenta, compared to normal placental development. (Figure taken from Lam 
et al., 2005) 
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Table 1.4.  Smoking and PE induced morphological changes and implications in the 
human placenta 
 
1.4 Hypotheses of the pathophysiology of PE  
There are a number of theories that attempt to explain the exact mechanisms involved in the 
development of PE. The leading theory of the disorder is that PE occurs in two distinct 
stages. Stage one depends on defective placental development, resulting in placental 
ischaemia and hypoxia, which leads to the second stage of maternal symptoms. Although the 
placenta may play a role in the development of PE, the maternal vascular endothelium 
appears to be responsible for the clinical manifestations observed (Roberts & Redman, 1993; 
Roberts & Cooper, 2001). Endothelial disruption in PE results in increased capillary 
permeability, vasoconstriction and end-organ ischaemia (Roberts & Redman, 1993). 
 
1.4.1 Circulating angiogenic factors implicated in the pathogenesis of PE  
Vascular endothelial growth factor (VEGF), and placenta-like growth factor (PlGF), promote 
angiogenesis, acting through the tyrosine kinase receptors, VEGF receptor 1 (VEGFR-1) and 
VEGF receptor 2 (VEGFR-2). Soluble fms-like tyrosine kinase 1 (sFlt-1), is an anti-
angiogenic factor and a splice variant of VEGFR-1 (Levine et al., 2009). sFlt-1 binds to 
circulating VEGF and PIGF preventing their interaction with endothelial cell receptors, in 
particular inhibiting VEGF stimulation of the nitric oxide system through VEGFR2 
(Venkatesha et al., 2006). sFlt-1 has been shown to be elevated in pregnant women with PE. 
Levine et al. (2004) have reported elevated levels in maternal serum five weeks before 
clinical symptoms appeared. Typically, PlGF is lower in pre-eclamptic women before the 
sflt-1 levels change with less consistent findings for VEGF (Ohkuchi et al., 2007).  
Placental 
Pathology 
Smoking PE Implications References 
Calcification 
    ↑   ↑  Reflection of cell death and degradation 
Klesses, 1998 
Sodhi, 1990 
Size of 
chorionic villi ↓ ? 
Compromised exchange of 
nutrients, gases and wastes 
Mayhew, 1996 
Transport of 
amino acids ↓ ↓ 
Intrauterine growth 
restriction (IUGR) 
Battaglia et al., 2001 
Sastry, 1991 
Apoptosis ↑ ↑ Cell death Sastry, 1991 
Hung et al., 2002 
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PlGF is expressed at high levels by trophoblast cells in the placenta. Low levels of free PlGF 
have been reported in the 1st and 2nd trimester in women developing PE (Akolekar et al., 
2010; Poon et al., 2009; Romero et al., 2008). Vatten et al. suggest that a low increase in 
PlGF concentration in early pregnancy, independent of change in sFlt-1, is associated with 
highly increased risk for preterm PE (Vatten et al., 2007). Also, lower urinary levels of PIGF 
have been reported at pregnancy weeks 25-28 following later development of PE. 
 
Soluble endoglin (sEng) is another anti-angiogenic factor that has been implicated in the 
pathogenesis of PE showing higher plasma sEng levels after pregnancy week 23-26 or 
approximately 8 weeks before the onset of clinical preterm PE. TGF-β interacts with 
endoglin receptor, which has been shown to be upregulated in the placenta in PE leading to 
increased secretion of the soluble form into maternal circulation. Placenta specific sEng 
appears to play a role in trophoblast invasion and differentiation (Levine et al., 2006; 
Romero et al., 2008; Venkatesha et al., 2006).  
 
At present it is unclear which factors trigger the excessive upregulation of placenta sFlt-1 
production. One proposed model has been the hypoxic condition of PE causing endothelial 
dysfunction and impaired angiogenesis. However, Savvidou et al. (2003) suggest that there 
is no direct causal effect between decreased level of second trimester maternal serum PIGF, 
increased level of sEng and the endothelial dysfunction assessed by flow-mediated dilation 
of the brachial artery. 
 
Combined, the above changes support the hypothesis that PE is a result of an exaggerated 
immunological response, which can disrupt trophoblast invasion leading to a reduced 
placental perfusion (Hennessy et al., 1999; Hung et al., 2004; Orange et al., 2003). PE is also 
associated with an up-regulation of inflammatory factors such as, tumour necrosis factor-
alpha (TNF-α), interleukins (IL) IL-1, -6, -8, -18, natural killer cells (NK), and oxygen free 
radicals, which contribute to the maternal endothelial dysfunction seen in PE (Hennessy et 
al., 1999; Hung et al., 2004; Orange et al., 2003). A common inducer of these changes is 
thought to be increased hypoxia. 
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1.5 Hypoxia and the placenta 
During in vivo placental development and before the opening of the intervillous space, 
placentation is known to occur in a low-oxygen environment, which is the stimulus of 
cytotrophoblast proliferation (Genbacev et al., 1996; Genbacev et al., 1997; Jaffe et al., 
1997). The amniotic cavity in normal healthy pregnancy, is normoxic, with oxygen levels at 
20% (Wang et al., 2010). In smoking and PE, this becomes hypoxic with estimated oxygen 
levels being 14% for smoking (calculated as a 30% decreased based on the findings of 
Benowitz et al., 1988, Jensen et al., 1991 and Socol et al., 1982) and 2% for PE (Genbacev et 
al., 1997). The mechanisms by which smoking and PE lead to the hypoxic levels are thought 
to differ. 
 
1.5.1 Cigarette smoke related hypoxia 
In addition to the vascular changes induced as a result of cigarette smoking, other secondary 
changes are also likely to occur. For example, smoking decreases the flow of uterine blood to 
the placenta (Castro et al., 1993) through mechanisms that include vasoconstriction. 
Conducive to this, placentas of mothers who smoke show morphological signs of reduced 
perfusion (Jauniaux et al., 1992). Furthermore, a key observation made by Shiverick and 
Salafia (1999) in the study of chorionic villous samples from early gestation was that the 
formation of trophoblast cell columns was markedly reduced in smokers. In this study, when 
chorionic villi from non smokers were exposed to nicotine in vitro, there was a dose related 
inhibition of cell column formation and reduced invasion of basement membrane, apparently 
related to decreased cytotrophoblast synthesis and activation of the 93 kDa Type IV 
collagenase (Genbacev et al., 1995). Recent studies with cultured trophoblasts demonstrated 
that hypoxic conditions inhibit the ability of cytotrophoblasts to differentiate along the 
invasive pathway (Genbacev et al., 1997). Given evidence that oxygen tension determines 
whether cells proliferate or invade, it is likely that smoking-induced hypoxia may be a factor 
in altered trophoblast differentiation. Alterations in trophoblast differentiation along invasive 
or proliferative pathways may explain the changes in endocrine function as well as vascular 
morphology that are observed in smokers (summarised in Table 1.4).  
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Signs of adaptive angiogenesis have also been reported in the foetal blood vessels within the 
mesenchymal cores of chorionic villi (Pfarrer et al., 1999), indicative of a compensatory 
mechanism that helps to increase blood flow to the foetus to overcome the induced hypoxic 
condition (Genbacev et al., 2003). 
 
1.5.2 PE related hypoxia 
After the opening of the intervillous space, the oxygen level within the placenta is ~6-8% 
(Jauniaux et al., 2000). In PE, decreased uteroplacental perfusion is the main 
pathophysiological mechanism behind increased hypoxic levels whereby it is decreased by 
50-70% (Lunell et al., 1982). Indeed failure of differentiation to the invasive phenotype is 
thought to compromise remodelling of maternal myometrial spiral arteries and may 
predispose the developing placenta to a state of chronic intermittent hypoxia and/or oxidative 
stress, as is the case in PE (Hung et al., 2002). Consequently, this may result in an 
intervillous oxygen concentration of ~2-4% (Zamudio et al., 2003).  
 
Typically, placentation is carried out in a hypoxic milieu. Existing dogma states that initially 
the spiral arterioles are plugged by extravillous trophoblasts allowing for early villous 
development and placental angiogenesis. Specifically, these processes are reported to occur 
at low oxygen levels of approximately 3%, similar to that which is necessary for VEGF 
induced nephrogenesis (Jauniaux et al., 2000).  Despite understanding the necessity of a 
hypoxic environment in creating a viable environment for the foetus, Fisher et al. (2006), 
found that hypoxia blocks cytotrophoblasts from differentiating into cells with an ‘invasive’ 
phenotype. Specifically, culturing the 6–8 week old villous explants in either 20% or reduced 
2% oxygen conditions, they noticed that both integrin α1 and histocompatibility antigen, 
class 1, G (HLA-G) expressions (two markers of invasive phenotype) were upregulated in 
20% oxygen, but  failed to express integrin α1 in 2% oxygen (Genbacev et al., 1997). These 
data suggest that at least some aspects of cytotrophoblast differentiation/invasion are arrested 
by hypoxia. Zhou et al. (1997) also reported that vascular endothelial (VE)-cadherin, an 
endothelial junction molecule, may help regulate the invasion process by allowing the 
cytotrophoblasts to “mimic” the adhesion molecule expression associated with endothelial 
cells. However, during experimental hypoxia, VE-cadherin is not expressed by 
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cytotrophoblasts in vitro. This finding is supported by an apparent lack of VE-cadherin 
expression in cytotrophoblasts in the placenta from cases of PE (Genbacev et al., 1996). As a 
result of these events, the failure to remodel the decidual spiral arterioles would limit 
placental vascular development, reduce the placental blood supply, and increase placental 
vascular resistance. Consequently, these events promote a further sustained hypoxic 
environment. Based on this it can be suggested that in pre-eclampsia, abnormally shallow 
cytotrophoblast invasion and faulty differentiation lead to inadequate vascular transformation 
(Genbacev et al., 1997; Zho et al., 1997). These observations collectively suggest that 
abnormal placental adaptation or insufficient trophoblast function contributes to the 
pathogenesis of PE.  
 
1.6 Suggested association between smoking and PE  
The biological mechanism underlying the relationship between smoking and reduced risk of 
PE, has not been established, however, recent research has implicated nicotine and carbon 
monoxide as the major mediators of this effect (Bainbridge et al., 2005).  
 
Nicotine, has been extensively studied for its pro-angiogenic properties (Heeschen et al., 
2001; Cooke et al., 2007) at concentrations found in the plasma of smokers (10-8 – 10-7 M) 
(Darby et al., 1984; Hill et al., 1983). A study conducted by Mimura et al. (2010), 
demonstrated that nicotine restored endothelial function damaged by excess sFlt-1 and/or 
sEng. As mentioned previously, PE is considered to be characterised by an anti-angiogenic 
state and maternal vascular endothelial dysfunction, which is caused by the release of 
excessive quantities of two major circulating anti-angiogenic proteins (sFlt-1 and sEng) into 
maternal blood (Venkatesha et al., 2006). Angiogenesis involves a variety of coordinated 
events, including matrix degradation, migration, proliferation, and morphogenesis. As 
mentioned previously, binding of nicotine to nAChRs on endothelial cells is considered to 
stimulate secretion of several pro-angiogenic growth factors, especially VEGF, which 
contribute to endothelial cell motility, proliferation, and morphogenesis (Jain et al., 2001; 
Conklin et al., 2002; Heeschen et al., 2002). Mimura et al. (2010) further showed in their 
study that sFlt-1 and sEng suppressed endothelial fundamental functions for angiogenesis, 
and suggested that nicotine restores these functions probably by its stimulatory effects on 
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secretion of growth factors. Therefore, it has been speculated that nicotine restores 
endothelial function damaged by excess sFlt-1 and/or sEng possibly through increased 
secretion of PlGF. For these aforementioned reasons it is anticipated that nicotine, or other 
nAChR agonists may have some therapeutic potential for PE via its pro-angiogenic 
properties. 
 
In addition to pro-angiogenic properties, nicotine also has anti-inflammatory properties 
(Wang et al., 2003; Wang et al., 2004). Nicotine blocks pro-inflammatory cytokine 
production induced by macrophages via nAChRs. It does this by preventing the activation of 
the nuclear transcription factor kappa B (NF-kB) (Wang et al., 2004) and inhibiting 
endothelial cell activation or adhesion molecule expression (Saeed et al., 2005; Speer et al., 
2002). Normal pregnancy is characterised by a mild systemic inflammatory response with 
evidence for an acute phase reaction and activation of multiple components of the 
inflammatory network (Borzychowski et al., 2006). In PE, the systemic inflammatory 
response is exaggerated (Borzychowski et al., 2006). Recently, a study conducted by 
Mimura et al. (2010) found that nicotine suppresses interleukin-6 production from vascular 
endothelial cells through the NF-kB pathway (Mimura et al., 2010).  
 
The protective effect of smoking on PE is likely multifactorial and summarised in Table 1.5. 
Although this thesis hypothesises the protective effects of smoking are via the nicotine 
component of cigarettes, we cannot exclude the effects of carbon monoxide. Carbon 
monoxide, although typically considered a toxic by-product of smoking, possesses important 
physiological functions (Bilban et al., 2006), including inhibition of pro-inflammatory 
cytokines and chemokines (Otterbein et al., 2000), prevention of vascular constriction 
(Zhang et al., 2001), inhibition of platelet aggregation and plasminogen activation (Fujita et 
al., 2001), inhibition and decrease of sFlt-1 (Powers et al., 2005), increase in heme 
oxygenase 1 (HO-1, an anti-oxidant) (Sidle et al 2007), and inhibition of apoptosis (Brouard 
et al., 2000; Liu et al., 2002). Additionally, carbon monoxide has been found to inhibit 
formation of reactive oxygen species (Wang et al., 2007) and inhibit apoptosis in the 
differentiated syncytiotrophoblast layer of the placenta (Bainbridge et al., 2006), 
predominantly attributed to its vasodilatory effects (Bainbridge et al., 2002).  
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Table 1.5. Smoking and PE induced biological changes of certain markers and 
implications in the human placenta 
 
1.7 Nicotinic acetylcholine receptors (nAChRs) 
The nicotinic acetylcholinergic receptors (nAChRs) belong to the cys-loop family of ligand 
gated ion channels. All nAChRs form as pentamers of subunits, arranged symmetrically 
around a central pore (Cooper et al., 1991) (Figure 1.4). Genes encoding a total of seventeen 
subunits (α1-10, β1-4, δ, γ and ε) have been identified. All subunits are of mammalian origin 
with the exception of α8 (avian) (Papke et al., 2008). nAChRs are found at skeletal 
neuromuscular junctions and autonomic ganglia as either homopentamers or 
heteropentamers. The predominant conformation of these subunits within the central nervous 
system (CNS) is heteromeric, although α7 and α9 homopentamers exist (Cohen et al., 2005). 
The conformation of nAChRs in the placenta currently remains unknown. The α1, β1,γ,δ and 
ε subunits are classified as muscle type (Ke et al., 1998) while the remaining are classed as 
neuronal.  In general, neuronal heteromeric nAChRs have higher affinities for nicotine than 
α7 homomeric nAChRs (Abbott et al., 2012). The composition of subunits in the receptor 
determines ligand specificity and affinity, cation permeability and channel kinetics. 
Classically, nAChRs are activated by the binding of endogenous acetylcholine (Ach). 
Marker PE Smoking Smoking + PE Implications 
sFlt-1 ↑ ↓ ↓ Reversed endothelial dysfunction (Mimura et al., 2010) 
PlGF ↑ ↑ ↑ Stimulates angiogenesis under 
conditions of ischemia, inflammation, 
and wound healing (Carmeliet et al., 
2001)  
VEGF ↓ ↑ ↑ Promoted angiogenesis, induction of 
NO and  vasodilatory prostacyclins in 
endothelial cells  ↓ vascular tone and 
blood pressure (He et al., 1999)   
IL-6 ↑ ↓ ↓ Reduced inflammatory response (Wang 
et al., 2003) 
Nitric Oxide  ↑ ↓ ↓ Endothelial dysfunction with reduction 
of dilatory capacity of vessels  
retarded foetal growth (Anderson et al., 
2004)  
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However, as suggested by the receptor name, nicotine can also bind at this same site and 
with greater affinity.  
 
Figure 1.4. General structure of a nicotinic acetylcholine receptor. (Figure taken from 
Wrightson Biomedical Publications, Petersfield, UK). 
 
1.7.1 Activation of the nAChRs  
Endogenously, the nAChRs are activated by acetylcholine (Ach). Exogenously, nAChRs are 
activated by nicotine and other agonists summarized in Table 1.6. The placental cholinergic 
system develops during the first half of pregnancy, and the highest Ach concentration is 
found at 20 weeks of gestation (Sastry et al., 1997; Sastry et al., 1976). Endogenously 
released Ach in the placenta is reported to regulate blood flow by dilating the placental 
vasculature and decreasing the resistance to foetal blood flow (Sastry et al., 1991). In 
addition, the contractile properties of placental myofibroblasts and active amino acid uptake 
are thought to be related to Ach release (Sastry et al., 1997). Early electrophysiology studies 
indicated that there are two Ach binding sites per nAChR. The binding sites reside at the 
interface between two adjacent subunits (Karlin et al., 2002; Sine et al., 2002). In the case of 
the muscle receptors, the two Ach molecules bind at the interface between the α-γ subunits 
(or α-ε in the adult form) and between the α-δ subunits (Osaka et al., 1999). 
 
 34
Nicotine stimulates nAChRs by binding to the two α-subunits. Exogenous agonists, such as 
nicotine, have different affinities for the different types of nAChRs (Lips et al., 2005). It was 
found in the Lips et al. (2005) study that nicotine binds with the highest affinity to α4β2 
nAChR and with 2-3 orders of magnitude lower affinity at α7 nAChR. It also binds with an 
intermediate affinity to receptors containing the subunit α3 (Lips et al., 2005). 
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Table 1.6. Binding affinities (K) and functional potencies for nicotinic agonists at native 
or recombinant α4β2 and α7 nAChRs and recombinant α3β4 nAChRs.  
Values are expressed as a range determined by the references cited below each entry. aBinding 
affinities reported for competition binding assays of [ H]-agonist binding (except [ H]-epibatidine) to 
brain membranes (α4β2* nAChRs) and [ H]-agonist binding to heterologously expressed nAChRs, [ 
I]-Bgt or [ H]- MLA binding to brain membranes or heterologously expressed α7 nAChR, [ H]-
epibatidine binding to heterologously expressed α4 nAChRs. bFunctional potencies reported at brain 
thalamic synaptosomes (*nAChRs) or heterologously expressed nAChRs. (Table taken from Sharples 
and Wonnacott, 2001). 
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1.7.2 nAChR expression and function in the human placenta 
Currently, the function of nAChRs in the placenta has been based on Ach binding only. It 
has been postulated that the placental cholinergic system develops during the first half of 
pregnancy, and the highest Ach concentration is found at 22 weeks of gestation (Sastry et al., 
1997). Ach is endogenously synthesized in the syncytiotrophoblast, after which it is released 
into both the foetal and maternal circulation of the placenta and is suggested to be an 
important placental signaling molecule that, through stimulation of nAChRs, controls the 
uptake of nutrients, blood flow and fluid volume in placental vessels, and the vascularization 
during placental development (Sastry et al., 1997).  
Despite the well known adverse effects of smoking during pregnancy, there has been no 
investigation of how it affects the expression or function of the nAChRs in the placenta. 
There are only two published reports to date concerning nAChR expression in the placenta 
(Kwon et al., 2006; Lips et al., 2005). Lips et al., (2005) reported the protein and mRNA 
expressions of eight nAChR subunits (α2-7, 9 & 10) in normal human and rat placenta, while 
Kwon et al., (2006) compared α7 expression between PE and normal placentas. These 
studies showed that the α2-7, 9 & 10 nAChR subunits are present in the placenta and that 
their level of expression varies according to cell type (Table 1.7).  
 
Table 1.7. Expression of nAChR subunits in the different cellular levels of the human 
placenta 
Data summarized from Lips et al., 2004. 
Subunit Location 
α2 - Villous endothelial cells 
- Syncytiotrophoblast (much less intense) 
α3 - Villous endothelial cells 
- Syncytiotrophoblast (much less intense) 
α4 - Syncytiotrophoblast 
- Decidual cells 
α5 - Syncytiotrophoblast 
- Endothelial cells 
- Decidual cells 
α7 - syncytiotrophoblast 
- Endothelial cells 
α9 - Enriched in basal membrane of the syncytiotrophoblast 
- Decidual cells 
- Endothelial cells of capillaries in terminal villi (weak immunolabelling) 
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In our laboratory, we have studied the mRNA expression of 16 nAChR subunits in the 
normal healthy placenta and subsequently compared the expression of 8 subunits (α2, α3, α5, 
α6, α7, α9, β1, and δ) in placentas of both smoking and PE (non smoking) mothers. We 
found increased expression of the α9 subunit and decreased expression of the δ subunit in 
placentas of smoking mothers, while in PE samples we found increased expression of the α2, 
α9 and β2 subunits. Changes at the protein level remain to be determined.   
 
1.8 Aim and hypotheses of this project 
 
1.8.1 Aim 
Using the experimental methods of western blotting (WB) & immunohistochemistry (IHC), 
the aims of the present investigation were to: 
1- determine normal protein expression (WB), localisation and distribution (IHC), of 10 
subunits (α2, α3, α4, α5, α7, α9, β1, β2, β4, δ) in the human placenta;  
2- determine which of the 10 subunits have changes in WB & IHC* expression when 
comparing: 
a) placentas from maternal cigarette smokers to non-smokers 
b) pre-eclamptic placentas to non-pre-eclamptics 
    * the IHC data will narrow down which cellular layer expresses these changes providing 
more precise mechanistic input. 
 
 
1.8.2 Hypotheses 
 
1- In the normal healthy placenta: 
 
a) based on previous placenta studies from our laboratory conducted at the mRNA level, 
it is expected that normal protein expression of the 10 nAChR subunits in the placenta 
will follow the same pattern observed in the decreasing order of mRNA concentration α3, 
α9, α2 > α5, β1 > δ, α7, α4, β2.  
b) based on the study conducted by Lips et al. (2005), it is expected that the protein 
expression of different nAChR subunits will vary at each cellular level, with those 
subunits being of a higher expression, more likely to be present in more cell types than 
those of low expression.  
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2- Comparing the smoking and PE placenta to the normal placenta in light of our previous 
mRNA findings: 
 a) in the placentas of smoking women, protein expression of the α9 and α2 subunits will 
increase while δ subunit will decrease; 
b) in the PE placenta; protein expression of the α2, α9 and β1 subunit will increase.  
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Chapter 2 
 
Methodology  
 
2.1 Patient recruitment and Placental tissue collection and fixation  
With the approval of the Sydney Local Health District Ethics Committee (Royal Prince 
Alfred Hospital (RPAH) zone) and that of the University of Sydney, after providing written 
informed consent, placental samples were obtained from women presenting to both RPAH 
and Campbelltown Hospital from April 2012 to July 2012. Women were recruited into three 
study groups: 1- those who had a healthy pregnancy and no report of smoking (normal 
group), 2- those who had a healthy pregnancy and did report smoking during their pregnancy 
(smoking group) and 3- those diagnosed with pre-eclampsia (PE group).  
 
Upon recruitment, clinical data pertaining to the mother and subsequently the baby when 
delivered, was obtained from the patient records at the hospital by our associate research 
midwife. History as to whether the mother smoked during pregnancy was also available in 
the records and further verified by measuring cotinine levels in either serum or placenta as 
recently reported (Ghazavi 2013).  Cotinine a breakdown product of nicotine was measured. 
It is the preferred biological marker for measuring precise cigarette smoke exposure as it has 
a much longer half-life (15–20 hours) and provides serum concentrations that are 10-fold 
higher than nicotine (Zevin et al., 1998). 
 
The placentas were collected from the operating theatre within 30 min of delivery. Four 
small (2 x 2 cm) separate samples were obtained systematically from different areas of the 
placenta. Samples were collected from the maternal side consisting of endothelial, villous 
and decidual cells. The samples were taken from the centre and one from each quadrant to 
avoid sampler bias. Two samples were immediately snap frozen in liquid nitrogen and stored 
at -80°C. The other two samples were washed in Dulbecco’s phosphate buffered saline 
(PBS) and were fixed for one day in 10% formalin. These samples were then processed for 
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paraffin embedding, which was carried out by the Department of Histology, RPAH and 
subsequently stored at room temperature. 
 
The frozen tissue blocks were used for the Western blot (WB) aspect of this study, while the 
formalin fixed and paraffin embedded (FFPE) blocks were used for the 
immunohistochemistry (IHC) part of this study. 
 
Due to a lack of time for recruitment, three cases in the PE group were sourced from our 
larger dataset which was developed in 2008. Additionally, these cases did not have FFPE 
tissue. As such, the dataset characteristics of the PE group in the WB and IHC studies are 
slightly varied. 
 
2.2 Sourcing and verification of nAChR antibodies 
The specificity and properties of the nAChR antibodies selected for this study have been 
substantiated by the published authors listed in Table 2.1. The ultimate test of antibody 
specificity is by its study in knockout tissue- this was only found for (α4,α5, β2, β4) (Table 
2.1). On our part, we further verified specificity by examining the antibody sequences using 
BLAST search (UNIPROT).  
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Table 2.1 Summary of nAChR subunit antibodies selected for this study 
 
^A kind gift from Jon Lindstrom, Medical School of the University of Pennsylvania
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2.3 Western blotting 
2.3.1 Protein extraction 
Protein extraction and immunoblotting were modified slightly from our previous protocol 
(Tang et al., 2009). Tissue samples (50 mg) were manually homogenized on ice in a lysis 
buffer (0.1 M EDTA, 1 M Tris HCL (Tris(hydroxymethyl)aminomethane hydrochloride), 
Triton (10%), 5 M NaCl, Protease Inhibitor) by pippetting and sonication. Samples were 
sonicated three times at 70% intensity in 10 second cycles. Samples were kept on ice for 
20 minutes and then centrifuged at 16 000g for 30 minutes at 4oC. Supernatant was 
collected and protein concentration was measured using Direct Detect Spectrophotometer 
(Millipore, Germany).  
 
2.3.2 SDS Polyacrylamide gel electrophoresis 
10% SDS polyacrylamide gels were used for electrophoresis (SDS, TEMED, 30% 
acrylamide, 10% APS).  
 
Placental tissue samples (10 µg/lane) were denatured at 90 oC for 5 minutes and 
transferred to ice immediately. Prior to loading, samples were centrifuged for 10 seconds. 
Placental samples and pre-stained molecular mass markers (Precision Plus Protein Dual 
Colour 161-0374, BioRad and Broad Range Markers sc-2361, Santa Cruz) were loaded 
into the gel for electrophoresis. Gels were run using a BioRad power pack cell at a 
running power of 90V for 100 minutes.  
 
2.3.3 Protein transfer and antibody incubation 
Once proteins were separated within the gel, proteins were transferred to a 
polyvinylidene fluoride (PVDF) membrane (Bio Rad; cat#170-4156) using Trans-Blot 
Turbo (Bio Rad, cat#170-4155). Following transfer, membranes were blocked in 5% 
skim milk in 0.1% tween 20-phosphate buffered saline (PBS) for 30 minutes before the 
membranes were incubated with the respective dilution of the primary antibody (Table 
2.1) overnight at room temperature (RT). The membranes were washed 3 x 10minutes in 
0.1%tweenPBS and then incubated with the respective horseradish peroxidase-
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conjugated secondary antibody (anti-goat, anti-rabbit or anti-mouse IgG; 1:2000) for 2 
hours at RT.  
 
2.3.4 Chemifluorescence and analysis 
Immunoreactive bands were detected using enhanced chemiluminescence (ECL) (Bio-
Rad ClarityTM Western ECL Substrate, Cat. # 170-5060) and visualized in Bio Rad 
ChemiDoc machine. ImageJ software (java based image processing program, developed 
by the National Institutes of Health, USA) was used for optical density (OD) 
measurement of the protein bands. Results were calculated and expressed as a ratio 
relative to beta actin loading control gene (Abcam 8226, 1:5000 dilution). Beta- actin was 
chosen as the loading control due to its stable expression in placental tissue (Wang et al., 
2000).  
 
2.4 Immunohistochemistry (IHC) 
 
2.4.1 Tissue sectioning 
Placental sections were cut at 7 µm from the FFPE blocks using a rotary microtome 
(Shandon Finesse 325, Thermo Fischer Scientific Inc, Massachusettes, USA). Sections 
were mounted on silanized superfrost slides ready for staining.  
 
2.4.2 IHC staining 
All reactions occurred at room temperature unless otherwise stated. Sections were 
deparaffinised in 2 changes of xylene and brought to water by a graded series of ethanol 
(100%, 100%, 95%, 95%, 70%, distilled H2O). 
 
Protein cross-linking occurs through formalin fixation (Shi et al., 1991). Thus, antigen 
retrieval was required to uncover antigenic sites. Our antigen retrieval method involved 
microwaving (Black and Decker, 700W, USA) sections in a 10% TRIS-EDTA buffer (1 
mM EDTA, 1 mM sodium citrate, 2 mM Tris; pH 9.0) for 13 minutes on high. This 
method was developed and optimized recently for use on placental tissue in our 
laboratory (Machaalani et al., 2008). The sections were brought to RT, rinsed with 
distilled H2O, and washed in PBS. A hydrophobic barrier was drawn around the sections 
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and then sections were quenched of endogenous peroxidase activity by immersing the 
slides in 3% H2O2, 50% methanol and PBS for 25 minutes. After washing in PBS, 
sections were blocked against proteins within the tissue that may cross-react with the 
secondary antibody and produce false positive staining. This was performed with 10% 
normal horse serum (NHS) in PBS for a 30 minute incubation period. Sections were then 
incubated with the respective antibodies, at dilutions listed in Table 2.1, at 4oC, 
overnight.  
 
After the overnight stage the sections were rinsed in 2 changes of PBS and then incubated 
with the respective biotinylated secondary anti-rabbit, anti-goat or anti-mouse antibody 
(VEBA-1100, VEBA-9500, VEBA-1400 Vector Laboratories Inc, California, USA) for 
40 minutes.  
 
After PBS washing, sections were incubated with avidin-biotin complex (ABC) labelled 
with peroxidase (VEPH4000, Vector Laboratories Inc, California, USA) for 40 minutes. 
The colour labelling was subsequently developed with 3, 3’-diaminobenzidine (DAB) 
(VESK3100, Vector Laboratories Inc, California, USA) for 7 minutes. Optimal  
incubation time with DAB was determined empirically. 
 
Sections were counterstained with Harris’s Haematoxylin for 25 seconds, washed in H2O, 
dipped 3 times in acid alcohol to remove excess stain, washed in H2O and stained in 
Scott’s Blueing solution for 2 minutes. Following H2O washing, sections were 
dehydrated through graded ethanol (70%, 95%, 95%, 100% and 100%; 1 minute each) 
cleared through xylene (2 changes, 5 minutes each), mounted and coverslipped with 
DPX. 
 
Negative control sections were treated as above but were incubated with 1% NHS instead 
of the nAChR subunit antibodies.  A minimum of 10% of cases had a duplicate section 
stained to ensure reproducibility of staining. Sections from all cases of the study were 
stained within the same day for each antibody to avoid day-to-day variation in staining. 
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2.5 Quantitative analysis for IHC 
2.5.1 Image Capture 
Images of the decidua, villous and endothelial cells of the human placenta were captured 
using a DFC400 camera (Leica Microsystems Ltd. Heerbrugg, Switzerland) mounted on 
a Nikon Eclipse e800 (Nikon Corporation, Tokyo, Japan) at 10x magnification. Five 
images of the decidual cells and 10 images of the villous cells were captured per section 
(at random but dispersed along the entire length of the tissue section) using leica 
application suite software (LAS V3.8, Leica Microsystems Ltd. Heerbrugg, Switzerland). 
Endothelial cells were observed within the villous cells.  
 
2.5.2 Quantitative Analysis 
Images were analysed using ImageJ software. Using the cell counter functions, the 
numbers of positive and negative trophoblasts were counted manually. These values were 
then exported to Microsoft Excel and calculated to express the percentage of villi with 
positive endothelial cells staining (EC), the percentage of positive stained endothelial 
cells per villous cell (% +ve EC), and decidua cells (%+DC). The intensity of the villous 
cells was manually determined and given a H Score ranging from 1-3 which accounts for 
staining intensity in conjunction with percentage of cells stained positively, with 3 
indicating greatest intensity (Demir et al., 2004). Scoring was performed by one observer 
only and the observer was blinded to diagnosis. A minimum of 10% of sections were 
double scored to ensure reproducibility of scoring.  
 
2.6 Statistical Analysis 
The patient characteristics of the control, smoker and PE groups were compared using 
one way analysis of variance (ANOVA) and data presented as mean and standard 
deviation (SD). 
 
For western blot analysis, the mean value of optical density (OD) was determined for 
each nAChR subunit, in each group. The results express this value ± the standard error of 
 46 
the mean (SEM). For IHC analysis the mean value was determined for each nAChR 
subunit, in each group and in each studied cellular layer. The results are expressed as 
mean ± SEM. 
 
Statistical analysis was performed using SPSS for Windows (V21; SPSS Inc., Illinois, 
USA). The results were compared among groups using multivariate general linear 
modelling with bonferroni’s adjustment. A p-value of <0.05 was considered statistically 
significant. Optical density (WB), the percentage of villi with positive endothelial cells 
staining (EC), % +ve EC and %+DC (IHC) were selected as the dependent variables, 
while the three diagnostic groups i.e. control, smokers and PE were the independent 
variables selected for the general linear model. 
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Chapter 3 
Results  
3.1 Patient characteristics  
A total of 23 women were studied and their group characteristics are shown in Table 3.1. 
The control, PE and smoker groups consisted of 8, 7 and 8 subjects, respectively for WB 
and 8, 8 and 8 subjects, respectively for IHC. Due to a lack of recruiting sufficient 
numbers of PE subjects during our collection period, three PE cases were derived from 
our larger dataset. The variation in n value for the PE group during WB and IHC 
experimentation is due to unavailability of FFPE tissue for these subjects and as such, 
two varying datasets were derived for WB and IHC.  
 
When comparing the control and PE groups, the weight of the newborn and the women’s 
blood pressures differed, with PE newborns being of a smaller weight (p=0.001), and PE 
women having a higher peak diastolic (p=0.0002) and peak systolic (p=0.001) blood 
pressure (Table 3.1). The mode of delivery, age, gestational age, booking systolic (first 
consultation) and diastolic blood pressures, Apgar scores at 1 and 5 min and birth weight 
centile were comparable with no significant difference between the two groups.  
 
When comparing the control and smoker groups, patient characteristics including age, 
gestation, mode of delivery, peak systolic BP, peak diastolic BP, booking systolic BP, 
booking diastolic BP, apgar scores at 1 and 5 min, birth weight and birth weight centile 
were comparable with no significant difference between the two groups. However, the 
reported use of tobacco and tissue cotinine concentration was statistically significant 
between groups (p = <0.001 and p = <0.001, respectively) as represented in Table 3.1. 
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Table 3.1 Patient characteristics of the Control, PE, and smoker groups. 
 
 
 
Note the 2 columns of PE- one representing the characteristics of the WB dataset, the 
other for the IHC dataset for the reason indicated in Methods Section 2.1. Data presented 
as mean ± SD. 
* Placental Cotinine levels were measured in our previous study (Ghazavi 2013) 
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3.2 Western Blot 
 
3.2.1 Antibody specificity  
 
From the western blot experimentation, we were able to verify antibody specificity 
according to the manufacturers’ specifications. The predicted size of subunits α2, α3, α4, 
α7, α9, β1, β2 and δ, obtained from either Santa Cruz or Abcam, ranged between 50- 78 
kDa. Respectively, their predicted sizes are 70 kDa, 55 kDa, 78 kDa, 53 kDa, 56 kDa, 50 
kDa, 55 kDa, 50 kDa and 59 kDa and these were mostly observed for all subunits except 
α2 (60 kDa instead of 70 kDa) and α4 (66 kDa instead of 78 kDa). For these subunits, the 
possible reasons for the inconsistent size may be due to dimeric or trimeric forms of the 
protein (Nicke et al., 1999). The product size of beta actin was consistently observed at 
42 kDa which was as expected.  
Unfortunately for β4, no signal was observed despite attempts of high concentrations of 
1:25 dilution. As such, this antibody was removed from the study. 
 
Figure 3.1. Antibody verification as compared to Santa Cruz Broad Range Marker. 
Note, in all images where 2 bands are observed, the bottom is the Beta-Actin. 
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3.2.2 Normal, control human placenta 
 
Based on the control placentas, greatest protein expression was observed for the α4 
subunit, while lowest expression was observed for the α7 subunit (Figure 3.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. Protein expression of the nAChR subunits in the normal, control human 
placenta determined by western blot.  The level of nAChR protein expression was 
measured as a function of optical density relative to beta actin.  
 
 
3.2.3 Comparing smoker and PE groups to controls (Figure 3.3) 
 
Comparing the expression of the subunits in smokers to controls, significantly increased 
expression was found for α9 (p=0.050) and δ (p=0.042). In PE compared to controls, 
significantly increased expression was found for α7 (p=0.004), α9 (p=0.024) and δ 
(p=0.003) subunits. Comparing the expression of the subunits between smokers and PE, 
significantly greater expression was found for β2 in the PE group (p=0.044) and a trend 
to decreasing β1 in the PE group (p=0.06) (Figure 3.3). 
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3.3 Immunohistochemistry of the nAChR subunits 
 
3.3.1 The normal human placenta 
 
Protein expression of the 9 nAChR subunits was observed at the cellular level via IHC 
experimentation. Expression of the subunits was quantified in three cellular layers 
including the endothelial cells, villous trophoblast and decidua cells. nAChR subunit 
staining was predominantly observed in the decidual cells (Figure 3.4), followed by the 
villous trophoblast cells and occasionally in endothelial cells (Figure 3.5). In the decidual 
cells, staining was primarily observed in the cytoplasm with the exception of staining 
observed for the β1 subunit which was mainly observed in the nucleus of the cells (Figure 
3.4).  
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Figure 3.3. Variation in protein expression between control, smoking and PE groups as 
determined by WB. Data are presented as mean + SEM. Statistically significant differences 
between control and smoking or control and PE groups are represented as *p <0.05 and **p 
<0.01. Statistically significant differences between smoking and PE groups are represented as #p 
<0.05. 
 
Deleted: P
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Figure 3.4 Staining in the decidual cells of normal, control human placenta. nAChR 
immunohistochemical staining in the normal placenta. Immunostaining in the human placenta 
showing positive staining for α2, α3, α4, α5, α7, α9, β1, β2 and δ nAChR subunits in the 
decidual cells and negative staining for α2 and α7  Bar = 50 µm for each panel. 
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Figure 3.5 Staining of villous cells in normal, control human placenta. nAChR 
immunohistochemical staining in the normal placenta. Immunostaining in the human 
placenta showing positive staining for α2, α3, α4, α5, α7, α9, β1, β2 and δ nAChR 
subunits in the villous (Outer layer of connective cells) and endothelial cells (within the 
villi). Bar = 50 µm for each panel. 
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3.3.2 Comparing smoker and PE groups to controls. 
 
Expression of the α3, α4, and α5, nAChR subunits in each of these cellular layers and 
between groups was comparable, with no significant differences.  
 
Control vs Smoker 
The α9 subunit expression in the EC of the control group was higher when compared to 
the smoker group (p=0.020). The β1 subunit H score (p=0.018) and %+DC (p=0.030) 
was significantly higher in the smoker group compared to the control group (Table 3.2)  
 
Control vs PE 
The β2 subunit expression of EC was greater in the control group when compared to the 
PE group (p=0.041). 
 
Smoker vs PE 
The %+EC and H score for the α2 subunit, were significantly higher in the smoker group 
when compared to the PE group (p=0.007, p=0.032 respectively).  For the α7 subunit, the 
EC and the %+EC was significantly higher in the PE group compared to the smoker 
group (p=0.009, p=0.047 respectively). It was found that the α7 subunit was more highly 
expressed in the decidual cells from placentas of smoking women compared to PE 
affected placentas (p=0.005).  
 
For the α9 subunit, the %+EC was significantly higher in the smoker group compared to 
the PE group (p=0.038). 
 
For the β1 subunit, the H score was found to be significantly higher in the smoker group 
compared to the PE group (p=0.029). Expression of the β1 subunit was significantly 
greater in the decidual cells of the smoker group compared to the PE group (p=0.037).  
 
Expression of the β2 subunit in EC, the %+EC, H score and expression in the decidual 
cells was greater in the smoker group when compared to the PE group (p=0.007, 
p=0.007, p=0.004, p=0.031 respectively).  
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Table 3.2. nAChR ICH protein expression in multiple cellular layers of the human placenta comparing amongst controls, 
smokers and PE. 
*p<0.05 compared to controls; # p<0.05 compared to PE
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Chapter 4 
Discussion 
4.1. Verifying smoking status 
 
Self reported habits of cigarette smoking are often underestimated (Dietz et al., 2011), 
thus it is important to have biological verification of smoking status. Cotinine, the 
primary metabolite of nicotine, due to its longer half life (approximately 15–20 hours), is 
the preferred biomarker to measure the level of tobacco smoking, and in serum/plasma 
samples, a level >14 ng/ml is taken to indicate active smoking (Jarvis et al., 1987, 
Schluter, 2002) although a lower cut-off point of 4.5 ng/ml has recently been suggested, 
taking into consideration ethnic variability (Benowitz et al., 2009). In our dataset as 
previously reported (Ghazavi 2013), serum samples from 3 patients were not available 
since these were sourced from a previous dataset due to the time limit of this study. Thus, 
for the purpose of including a complete set of results, serum was directly extracted from 
the placental tissue and measured using ELISA analysis. However, to validate that this 
method is acceptable since at the time of our study, no reports of such a method were 
available in the literature, we compared cotinine levels between the venous serum and 
placenta-derived serum in the 5 patients from which both were available. We found that 
the mean of the two sample types was >85 ng/ml, categorising them in the high active 
smoking range. However, venous blood levels were on average 20 ng/ml higher than 
placental levels. Only recently has a study been reported comparing venous serum to 
placenta derived homogenate from a pregnant mouse model of cigarette smoke exposure 
(Vyhlidal et al., 2013). In support of our findings, these authors also showed a higher 
median level of cotinine in serum versus placenta and that this was positively correlated. 
Taken together, our findings indicate that measuring placenta-derived serum cotinine 
levels is a reliable indicator of cigarette smoking status. 
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4.2. nAChR subunits in the normal placenta 
To date only two studies have looked at the expression of nAChRs in the human placenta, 
reporting the expression of the α2-7, α9 and α10 nAChR subunits in the normal healthy 
placenta (Lips et al., 2005) and α7 subunit in the normal placenta compared to PE 
placentas (Kwon et al., 2006).  
 
Our findings, from a prior study, support those of Lips et al., (2005), and show 
additionally that the remaining (previously not studied) subunit mRNAs, including α1, 
β1, β2, β3, β4, δ, ε and γ, are also expressed in the human placenta (Ghazavi, 2012). 
Among the 16 subunits studied, it was observed that mRNA levels of certain subunits 
were greater than others, in the order β4>α3, α4, α9 > α2, α6, α10, β2, ε > α1, α5, α7, β1, 
β3, δ, and γ (Ghazavi, 2012). Findings from the current investigation demonstrate that at 
the protein level this pattern was retained, with the exception of α3 and α9, which were in 
the middle expression range rather than high expression range. Combined, mRNA and 
protein expression data suggest that in the non-diseased human placenta, ACh action on 
the nAChRs may occur predominantly via receptors containing α2, α3, α4, β2 and β4 
subunits. All of these subunits are neuronal-type, based on the 4 subfamily divisions as 
reported by Le Novere and Changeux (1994) (summarized in Table 4.1).  
 
Table 4.1. Subfamily division of the nAChRs. 
Neuronal-type Muscle-type 
I II III IV 
α9, α10 α7, α8 1 2 3 
 
α2, α3, α4, 
α6 β2, β4 β3, α5 
α1, β1, δ, γ, 
ε 
The nAChRs have been divided into 4 subfamilies (I-IV) based on similarities in protein 
sequence (Le Novere and Changeux, 1994). In addition family 3 has been further divided 
into 3 tribes. 
 
Most nAChR subtypes appear to exist as heteropentamers containing two or more 
different subunits. Heterologous expression studies suggest that α2, α3, α4, and α6 
subunits can combine in binary fashion with β2 or β4 to form functional nAChRs, while 
α5 and β3 subunits are considered “wild-cards” not able to form nAChRs alone or with 
any other single type of subunit, but rather combine as trinary (e.g., α4β2α5, α3β4α5) or 
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quaternary (e.g., α4α6β2β3- or α3β2β4α5) complexes (Wu and Lukas 2011). The muscle-
type nAChRs are quaternary complexes composed of α1, β1, δ and either γ (foetal) or ε 
(adult) subunits. The α7 and α9 subunits are unique in that they form functional 
homopentamers, although the function of the α9 subunit is enhanced when it co-
assembles with the α10 subunit (Sgard et al., 2002).  
 
It is interesting to note that the α3, α4, β2 and β4 subunits were amongst the intermediate 
to higher expressing subunits in the normal healthy placenta. Functionally, the α3 subunit 
is important for body growth, bladder contractility, and pupil dilation, functions 
determined while examining α3 knockout mice (Xu et al., 1999a). Survival of these α3 
knockout mice was also threatened, with >50% dying within the first postnatal week and 
most likely due to bladder and/or urinary tract infection (Xu et al., 1999a). Other 
functions of the α3 subunit are derived from expression studies. The α3 subunit is present 
on the resident macrophages (Hofbauer cells) in the full term human placenta (Lips et al., 
2005), and in cultured human bronchial epithelial cells, the α3 subunit stimulates the 
release of granulocyte macrophage colony stimulation factor (Klapproth et al., 1998), 
thus indicating a potential role for the α3 containing nAChRs in regulating 
cytokine/chemokine secretion. In skin keratinocytes and bronchial epithelial cells the α3 
subunit appeared to be involved in the maintenance of the flat shape of the cells (which is 
necessary to form a continuous epithelial lining) (Macklin et al., 1998; Maus et al., 
1998). The role of the α4 subunit in the placenta remains in question given that the only 
role of the α4 subunit to date is in nociception as determined by α4 knock-out mice 
(Marubio et al., 1999). 
 
The β2 and β4 subunits are integral for the formation of ACh binding sites and effective 
ion channels in nAChRs (Xu et al., 1999b). The α3β4 and α4β2 functional nAChRs are 
abundant on autonomic ganglia (Corriveau and Berg 1993). The α3β4 assembly is 
important for ACh-induced fast excitatory postsynaptic transmission in the autonomic 
nervous system (ANS) (Wang et al., 1996; Nelson and Lindstrom, 1999), with a lower 
affinity for nicotine than the α4β2 assembly (Corriveau and Berg 1993). Based on β4 
knockout studies, it was shown that animal survival was not at risk but the animals did 
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have an impaired heart rate response to cervical vagal stimulation, and greatly reduced 
ileal contractile responses, suggesting that β4 subunits are critical in the ANS for the 
formation of functional receptors with α3 subunits, and that their deficiency adversely 
affects autonomic transmission, most probably by the loss of ACh binding sites in ganglia 
and by the alteration of properties of ion channels and affinities of some drugs (Wang et 
al., 2003). 
 
Taken together, the above data indicate that nAChRs in the non-diseased human placenta, 
containing α3, α4, β2 and β4 subunits, which are requisite participants in the majority of 
functional ganglionic nAChRs (Xu et al., 1999b), may play the predominant role in 
facilitating the endogenous ACh mediated cellular growth, maintenance and survival, as 
well as nociception and contractility of the placenta.  
 
4.3. Effect of smoking and PE on nAChR subunit protein expression in 
the human placenta compared to controls 
 
This study was limited to nine of the sixteen mammalian nAChR subunits due to the 
availability of antibodies that are well characterised and have had their specificity 
determined. Although we were kindly provided with some mouse monoclonal antibody 
against the β4 subunit (mAb337, Jon Lindstrom, Medical School of the University of 
Pennsylvania), we did not see any signal in the western blot and as such, this subunit was 
excluded.   
 
IHC analysis encompassed 3 major cell/structure types: endothelial cells (EC), villous 
cells, and decidual cells. Each cell type has an important regulatory function as described 
in section 1.3.2. By undertaking the IHC study, we aimed to narrow down which of the 
cell types were showing the changes in expression to determine functionality. This could 
not be done with western blotting since tissue was derived from an arbitrary small block 
of placental tissue of the maternal interface where the constituent proteins derived were 
heterogeneous (of different cell types), and for some cases, protein derived from one cell 
type may have been greater than in other cases. Nevertheless, the western blot data from 
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this study showed that when compared to the control group, α9 and δ were increased in 
both the smoker and PE groups. An increase in α7 was additionally seen in the PE group.  
 
Consistent with the western blot findings, a change in α7, α9 and δ subunit expression 
was observed at the cellular level using IHC, with additional, changes for α2 and β1 
subunit. Specifically, for α7, the percentage of positive endothelial cells per villous was 
decreased in the smokers compared to both control and PE groups. For α9, a decrease 
was observed for the percentage of villi with positive cells in PE compared to controls 
while a lower percentage EC per villous in PE was evident compared to smokers. δ 
subunit expression was increased in the decidual cells of smokers compared to the control 
group. For α2, the percentage of positive EC per villous and the villous cells was greater 
in the smoker group compared to the PE group. Finally, β1 expression was increased in 
villous and decidual cells of smokers compared to control and PE.  
 
4.3.1 Mechanism(s) leading to a change in α9 and δ expression  
Our finding that the expression of α9 and δ subunits increased in both the smoking and 
PE groups compared to controls suggests a possible common mechanism causing this 
increase. Given both conditions induce hypoxia, we suggest this to be the common 
mechanism. At the cellular level, it was unexpected to see an opposite effect of decrease 
in α9 expression in the PE group, albeit only in the EC cell type. The implications of this 
finding will be discussed and summarized in Figure 4.1. 
 
4.3.1.1 α9 subunit  
Typically, nicotine acts as an agonist at nAChRs. However, nicotine has been shown to 
have a unique, antagonistic effect on α9-containing nAChRs. Recombinant α9α10 
nAChRs (expressed in Xenopus laevis oocytes) were activated by ACh but inhibited by 
nicotine (Rothlin et al., 2003, Sgard et al., 2002, Verbitsky et al., 2000).  Although the 
predominant role of α9 is reported to be in auditory regulation (Vetter et al., 1999), the 
α9-containing nAChRs are found mainly outside of the CNS (Colomer et al., 2010, 
Kummer et al., 2008, Lips et al., 2005) and play a role in keratinocyte adhesion (Nguyen 
et al., 2000) and re-epithelialization (Grando 2006), in mediating synaptic transmission 
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between the efferent olivocochlear fibres and cochlear hair cells (Maison et al., 2002, 
Vetter et al., 1999), and regulation of pain (McIntosh et al., 2009, Vincler et al., 2006).  
 
The placenta of smoking women has shown increased trophoblastic apoptosis 
(Genbachev et al., 1995, Jauniaux and Burton 1992, Nelson et al., 1996), and this was 
found to induce a discontinuity in the trophoblatic layer of the villi (Nelson et al, 1996). 
A discontinuity in such a tissue layer (trophoblast) provides a matrix for re-
epithelialization which is a mechanism of villous repair (Nelson et al., 1990). A role of 
α9-containing nAChRs in re-epithelialization has been reported whereby antagonism of 
α9 and RNA interference in keratinocyte cultures and null mutation in knockout mice 
delayed wound re-epithelialization in vitro and in vivo (Grando 2006). Thus, our finding 
of increased α9 nAChR expression in placentas from smoking women and those with PE 
may indicate an increase in its stimulation via ACh to increase the re-epithelialization of 
the trophoblast due to damage caused by smoking- and PE-induced apoptosis.  
 
During pregnancy, the developing foetus is totally dependent on maternal amino acid 
supply, via the placenta, for protein synthesis and growth in size and weight (Pastrakuljic 
et al., 1999). Smoking- and PE-induced hypoxia, reduce ACh levels, in turn depressing 
active amino-acid uptake which is thought to be a major mechanism for IUGR of the 
foetus (Pastrakuljic et al., 1999, Sastry et al., 1991). Lips et al. (2005) found strong α9-
immunolabelling localised in the syncytiotrophoblast, with a distinct enrichment in the 
basal membrane. Amino acids must cross both the maternal-facing microvillous plasma 
membrane and foetal-facing basal plasma membrane of the placental syncytiotrophoblast 
in order to reach the foetal circulation. Thus, regulation of amino acid uptake is a 
potential role for α9 containing nAChRs expressed in the syncytiotrophoblast. Given we 
found an increase in α9 expression in both the smoking and PE group, this may indicate a 
positive effect on active amino acid uptake via α9-containing nAChRs, potentially 
counteracting a decrease in amino acid uptake as a result of decreased ACh due to 
smoking and PE (Sastry et al., 1995). 
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Finally, both α9 and α10 are expressed in a variety of immune cells (Kawashima et al., 
2007). McIntosh et al (2009) identified the α9 and α10 subunits in Jurkat, MT2 and CEM 
T-cell lines, purified populations of CD3+, CD4+ and CD8+ T-cells, CD19+ and CD80+ 
B cells, monocytes, macrophages and in tonsil (Lustig et al., 2001, Peng et al). The 
maternal-foetal interface is high in immune cells which cross-talk with hormonal, 
endocrine, and angiogenic regulators to program a normal pregnancy outcome. Among 
immune cell types, regulatory T cells play an important role in protecting the foetus by 
dampening harmful inflammatory immune responses at the maternal-foetal interface 
(Somerset et al., 2004). Placental hypoxia amplifies release of inflammatory stimuli into 
the maternal circulation. This might involve lipid peroxidation or other, undefined 
mechanisms. Hypoxia could also activate leukocytes (Scannell, 1996) in the intervillous 
space or stimulate proinflammatory cytokine production by the placenta (Benyo et al., 
1997). Thus, it is possible that α9 expression is increased to dampen the inflammatory 
response caused by smoking- and PE- induced hypoxia.  
 
Although our finding of decreased α9 immunostaining in the endothelial cells of PE 
samples is contradictory to the increase seen in the western blot data, it is not unusual. 
For example, haeme oxygenase-2 (HO-2), a regulator of carbon monoxide production 
and a potent vasodilator (McLean et al., 2000), was found to be unaffected in western 
blot experimentation of PE placentas, yet at the cellular level, it was found to be 
decreased in endothelial cells (Barber et al., 2001). Given PE has been ascribed to 
generalized maternal endothelial cell dysfunction (Redman et al., 1999), this specific 
finding of a decrease only in the ECs supports the role of the α9 subunit in the abnormal 
vascularisation seen in PE.     
 
4.3.1.2 δ subunit  
The δ subunit belongs to the muscle- type nAChRs which are pentameric complexes, 
consisting of four distinct protein subunits (α1, β1, δ, γ). The γ subunit is substituted for 
the ε subunit with age, altering the functional response of the receptor (Camacho et al., 
1993; Mishina et al., 1986). The binding of two molecules of ACh to specific sites at the 
interface of the α subunits with the γ and δ subunits causes a conformational change in 
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the receptor protein allowing ion permeation (Blount and Merlie, 1989). Each subunit 
shares a characteristic configuration containing a large N-terminal hydrophilic sequence, 
followed by four putative transmembrane domains (Changeux et al., 1992). Previous 
studies have demonstrated that the second transmembrane domain (TM2) of each subunit 
lines the ion channel pore. This region plays a role in determining the divalent 
permeability of the receptor as well as determining pharmacological properties 
(Changeux et al., 1992).  
 
Genetically, the δ subunit is linked with the muscle disorder of myasthenia gravis, where 
the level of the δ subunit mRNA coding for the adult nAChR is increased (Guyon et al., 
1998). Thus, the role of the δ subunit seems to be specific in regulating synaptic activity 
and ion conduction pathways within muscle, particularly Ca2+ (Carlisle et al., 2004, Zia 
et al., 2000). Although a direct action of this is via nicotine activating δ-containing 
nAChRs directly, it has also been reported to be via the role of the δ subunit in increasing 
affinity of nAChRs to non-competitive inhibitors (NCIs) (Francis and Papke, 1996). 
NCIs prevent receptor function by binding to sites which are believed to block the ion 
conduction pathway and which are distinct from the binding sites for agonist activation. 
Hence, our finding that the smoke exposed and PE affected placenta had an increase in 
the δ subunit, suggests this may have caused an increase in the affinity of NCI for the 
nAChR. By doing so, Ca2+ permeability through these ion channels is decreased. As 
such, exaggerated energy expenditure, impaired energy production, initiation of 
cytoskeletal degradation, and ultimately cell death (apoptosis) are reduced (Nicotera et 
al., 1998). Therefore, this increase in δ by smoking and PE may reflect a compensatory 
protective physiological response.  
 
Expression of δ subunit was increased in decidual cells of smokers compared to controls. 
The decidual cells provide nutrition to the developing embryo, protect the embryo from 
immunologic responses from the mother, and regulate trophoblast invasion into the 
uterine stroma (Kowaka et al., 1998). Smoking is known to reduce the exchange of 
nutrients from mother to foetus, depress active amino-acid uptake by human placental 
villi and trophoblast invasion (Jauniaux et al., 2007). It is therefore possible that 
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increased expression of δ in the decidual cells of smokers is mediating the adverse affects 
of smoking by inhibiting activation of the decidual cells and therefore their function. 
 
4.3.2. Mechanism(s) leading to a change in α7 expression  
Previously, our laboratory found no change in α7 nAChR expression at the mRNA level 
in either smoking (Ghazavi, 2012) or PE placentas (David, 2012). However, via western 
blot, an increase in the protein expression of the α7 subunit was observed in PE compared 
to control placentas. This is consistent with the findings of Kwon et al. (2006), the only 
other group to look at α7 nAChR expression in the PE placenta. An additional 
observation of this study was that at the cellular level, α7 expression is lower in the EC of 
smokers compared to both control and PE groups.  
 
The α7 nAChR subunit was initially found in the nervous system (Flood et al., 1997). Its 
expression in non-neuronal cells, such as macrophages (Heeschen et al., 2002; Saeed et 
al., 2005), endothelial cells (Heeschen et al., 2002), alveolar type II cells (Sekhon et al., 
1999), smooth muscle cells (Macklin et al., 2008), and the placenta (Lips et al., 2005), 
was only discovered recently. 
 
Disruption of α7 nAChR subunit expression has been shown to significantly inhibit 
inflammatory angiogenesis and reduce ischaemia-induced angiogenesis, suggesting a role 
for the α7 nAChR subunit in mediating the angiogenic pathway (Heeschen et al., 2002). 
This is mediated by both ACh and nicotine. ACh-mediated anti-inflammatory activity via 
the α7 nAChRs has been reported by Shytle et al., (2004) and Wang et al., (2003). Nizri 
et al (2006; 2008) further showed the suppression of lymphocyte proliferation and the 
reduction of pro-inflammatory cytokine production upon treatment with inhibitors of 
acetylcholinesterase.  
 
Evidence for nicotine-mediated anti-inflammatory effect of the α7 nAChR subunit is 
more diverse. Wang and colleagues (2003) observed that the amount of tissue necrosis 
factor (TNF) released from lipopolysachharide-stimulated human macrophages decreased 
when they were treated with nicotine and that this effect was absent when they were 
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pretreated with α-bungarotoxin, an α7 nAChR subunit blocker. Similarly, a study 
conducted by Saeed et al. (2005) showed that nicotine suppressed endothelial cell 
activation via the α7 subunit, whereby TNF induced adhesion molecule expression and 
chemokine production by endothelial cells was inhibited, and leukocyte migration during 
inflammation was blocked. Nicotine also prevented hypoxia-induced cell membrane 
disintegration and DNA fragmentation via the α7 nAChR subunit (Hejmadi et al., 2003; 
Tohgi et al., 2000). When cells over expressing the α7 nAChR subunit were pretreated 
with nicotine, the tolerance to G1 arrest and DNA fragmentation was increased 
(Utsugisawa et al., 2002). Considering these observations, a clear role of the α7 nAChR 
subunit in inflammation and endothelial cell activation in the placenta is evident and this 
difference may be involved in the pathophysiology of PE.  
 
4.3.3 Mechanism(s) leading to a change in β1 expression 
The greater expression of β1 in the villous and decidual cells of smokers compared to 
both control and PE groups, suggests a purely nicotine (rather than hypoxia-driven ACh) 
induced effect.  
 
An analysis by Su et al. (2002) indicated that the β1 subunit is abundantly expressed in 
the neuromuscular junctions of muscles and components of muscular subtypes that cause 
excitatory effects on muscle leading to contraction. Commonly, β1 conforms with 3 other 
subunits α1, δ, and either γ (foetal) or ε (adult) (Giniatullin et al., 2005), this combination 
referred to as the muscle type nAChRs. The muscle type nAChRs are known to play a 
key role in ion channel permeability and increase Ca2+ influx at the nAChRs. Increases in 
Ca2+ cause apoptosis and lead to calcification. The placenta of smoking women has 
shown increased trophoblastic apoptosis (Genbachev et al., 1995, Jauniaux and Burton 
1992, Nelson et al., 1996), and this was found to induce a discontinuity in the 
trophoblastic layer of the villi (Nelson et al., 1996). It is therefore possible that increased 
expression of β1, via nicotine from cigarette smoke, is implicated in the increased 
calcification and apoptosis seen in the trophoblast (Jauniaux et al., 2007) of placentas 
from smoking women although it is understood not all cellular calcium changes translate 
to clinically relevant calcification (Figure 4.1).   
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4.4 Differences between smokers and PE: α2 and β2  
This study aimed to recruit a PE+smokers group however given the study time-frame, we 
were unable to achieve this. Thus, the precise mechanism in this group remains 
outstanding and our analysis comparing smokers to PE is speculative. The discussion will 
propose a possible protective role of smoking in PE via the specific subunits where a 
difference in expression between the two groups was observed; these being α2 and β2.  
 
4.4.1 α2 subunit 
Between the smoking and PE groups, we found the percentage of positive EC per villous 
and the villous cells containing α2 was greater in the smoker group compared to the PE 
group.  The α2 subunit was among the first non-muscle nAChR subunits to be cloned and 
heterologously expressed in a functional subtype, with the β2 subunit (Wada et al., 1989). 
In a study comparing the functional properties of rat nAChR α2β2 channels to α4β2 
channels, it was found that low doses of nicotine and ACh were equally effective at 
activating α4β2 channels, whereas nicotine was more potent than ACh at α2β2 channels 
(Khirough et al., 2004; Luetje and Patrick, 1991). Thus it was not surprising to see 
greater expression of α2 in the smokers, presumably as an effect of nicotine from the 
cigarette, which is not present in the PE group. It is however understood that any 
observed changes can not be unequivocally attributed to nicotine alone as the comparison 
was between smokers and PE as opposed to the control group. 
 
In the study conducted by Lips et al, (2005), weak to moderate α2/4-immunolabelling 
was detected intracellularly in the syncytiotrophoblast. The nAChR in placental vessels 
are suggested to be involved in the cholinergic regulation of blood flow and fluid volume 
(Sastry, 1997).  In the present study, expression of the α2 subunit was found to be greater 
in the smokers compared to PE. Expression of the α2 subunit has been demonstrated 
within the synctiotrophoblast where amino acid transporters can be found (Lips et al., 
2005). Accumulative amino acid transporters and exchangers can account for the net 
uptake of amino acids from the maternal circulation across the microvillous membrane 
into the placenta (Cleal & Lewis, 2008). Although other subunits have been observed in 
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the syncytiotrophoblast, α2 is one of the most highly expressed subunits (David, 2012, 
Ghazavi, 2012). One may therefore speculate that greater expression of α2 subunit in 
smokers compared to PE may be occurring as a protective mechanism whereby a 
decrease in ACh, therefore reduced placental uptake of amino acids, caused by PE-
induced hypoxia, is being counteracted by an increase in α2 subunit expression, as seen 
in smokers. 
 
4.4.2 β2 subunit 
This study found that β2 expression was less in the smokers compared to PE, as 
determined by western blot.  A role of β2 in inflammatory processes, regulating cytokine 
production (blocking or inhibiting), has been reported (Bencherife et al., 1996). 
Importantly, while the α4β2-selective ligand (E)-metanicotine inhibits IL-8 and TNF-
α production in human macrophages and in cells of the inflamed mucosa (Spoettl et al., 
2007), nicotine down-regulates the production of proinflammatory cytokines in β2-
containing murine alveolar macrophage (MH-S) cells (Matsunaga et al. 2001). This 
effect was blocked by the antagonist d-tubocurarine (selective for β2 containing 
receptors) but not the antagonist α-bungarotoxin (selective for α7 containing receptors). 
Furthermore, a recent paper shows that nicotine blocks cytokine production in mouse 
macrophages that lack α7 subunits but express α4β2 receptors (van der Zanden et al. 
2009). When studying α4β2, Hosur et al. (2009) found that nicotine suppresses 
proinflammatory cytokines IL-1b and IL-6 in ha4b2 SH-EP1 cells in a time- and 
concentration-dependent manner. Further, selective antagonists dHbE and Mec reversed 
nicotine-induced suppression of proinflammatory cytokines suggesting that α4β2 receptor 
activation is required to inhibit activation of the NFkB pathway and in turn attenuate 
cytokine synthesis.  
 
Studies have demonstrated that up-regulation of α4β2 receptors requires receptor 
occupation, but not necessarily ion flux through the receptors (Gopalakrishnan et al. 
1996; Darsow et al. 2005). It is therefore possible that although β2 expression was greater 
in the PE group, the functionality of receptors containing this subunit was not increased. 
Furthermore, given the heightened inflammatory response in PE and the anti-
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inflammatory role of nicotine at the α4β2 nAChR, it is possible that nicotine may reduce 
the inflammation that is highly characteristic of the pathophysiology of PE. 
 
 
 
 
Figure 4.1. Diagram summarizing nAChR subunit role in pathophysiology of 
smoking and PE. Both smoking and PE induce hypoxia. This study proposed that 
expression of δ and α9 was increased in both smokers and PE as a physiological response 
to minimize hypoxia induced apoptosis, calcification and inflammation due to the 
inherent properties of these subunits. Alone, smoking was found to increase expression of 
β1. This muscular type nAChR has a role in receptor excitability and when stimulated by 
nicotine causes Ca2+ influx. Subsequently, apoptosis and calcification result and 
therefore, this subunit may have a role in the adverse pathology seen in placentas from 
smoking mothers. Alone, α7 expression was found to increase in PE. This subunit has a 
reported role in inflammation and therefore may be implicated in the hallmark increase in 
inflammation experienced in PE. The change in α2 and β2 expression did not occur 
relative to controls and therefore the role of these subunits is speculative and not included 
in the above figure. 
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4.5 Limitations 
As with all studies this one was limited by a number of factors: 
1) Given the short time frame of the project only the minimum number of cases 
required per group was achieved thus resulting is a relatively small data set. The 
minimum required number of cases was determined by power calculations 
according to a previous study of nicotinic receptors in brain tissue from piglets 
exposed to nicotine in our laboratory where an n value of 7 per group resulted in p 
values <0.05 (Browne et al., 2010).  
2) The amount of cigarettes smoked by the mother was derived from the patient 
records in the hospital. As such, bias may have been involved in underreporting 
this habit. This would have been a confounding factor. However, this was 
overcome by measuring cotinine levels (Ghazavi 2013) which allowed for 
biological verification of the extent of maternal smoking.  
3) Although this study aimed to investigate the protective mechanism of smoking on 
PE a combined sample set for placentas from women who both smoked and had 
PE during pregnancy was unable to be recruited mostly because of the association 
of preeclamptic smokers being a rarity. Therefore, it has been acknowledged that 
any association between the two groups is speculative.  
4) Experimentally, both the Western blot experimentation and IHC involved the use 
of antibodies. Although all antibodies were verified to the best of our ability from 
available literature, it is not until knock out models are developed for them that 
specificity can be ascertained.  
 
4.6 Future directions 
Some discordance was observed between the WB and IHC data. We presume this to be 
due to the origin of the final protein content in WB where we did not differentiate 
between the cell types of the placenta. Future studies using cell separation (Cervar et al., 
1996) and measuring the amount of protein from each cell type would provide a more 
precise cellular analysis.  
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Although nicotine is the major pathogenic compound of cigarette smoke and one of the 
major agonists at the nAChRs, future studies may be better able to elucidate the effects of 
nicotine on nAChRs by looking at the specific effect of this compound via the collection 
of placentas from women who used nicotine patch therapy (NPT) during their pregnancy. 
This could help demonstrate whether nicotine has a specific effect on the development of 
the foetus by inducing a change in receptor subunit expression. Animal studies could also 
help elucidate the specific effect of nicotine on the nAChR subunits, whereby pregnant 
rats are exposed to nicotine during pregnancy and their placentas subsequently studied. 
Knock out models would also be an effective way of further investigating the role of each 
nAChR subunit at an individual level. Such models would allow the functional role of 
each subunit to be more precisely studied.  
 
The recruitment and analysis of placental samples from women who both smoked and 
were diagnosed with PE (PE+smokers) during pregnancy would be a more significant 
method of elucidating the proposed protective role of smoking on PE whereby a more 
direct correlation could be drawn between these two factors. 
 
Given we found that 6 of the 9 subunits had differences amongst the three groups, future 
receptor binding studies focusing on these receptor subtypes would be valid. This is 
indeed feasible given we have frozen placental tissue and radioactive markers are 
available on the market, although it may be time consuming and costly. Such 
experimentation would however, provide precise data on actual receptor functionality. 
 
4.7 Conclusion 
This study was novel in finding the additional protein expression of the β1, β2 and δ 
nAChR subunits in the normal, non-diseased human placenta. Of the nine subunits 
studied (α2, α3, α4, α5, α7, α9, β1, β2 and δ), α3, α5 and α9 were most highly 
expressed in the normal, non-diseased human placenta. These three subunits are known to 
have an important role in vasodilation which is necessary for healthy blood flow within 
the placenta, between the maternal and foetal circulation.   
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This study subsequently demonstrated, for the first time, changes in nAChR subunit 
expression in the placentas from women who smoked during pregnancy or had developed 
PE, and attempted to elucidate, albeit indirectly, the protective role of smoking on PE.  
Results showed that α9 and δ were increased in both the smoker and PE groups. It is most 
likely that this was a physiological response attributable to both smoking and PE-induced 
hypoxia rather than purely a response to one of these factors alone. An increase in α7 
expression was additionally seen in the PE group and this can be implicated in the 
increased inflammatory response which characterizes PE. Expression of β2 was greater in 
the PE compared to smoker group and it is thought smoking may be inducing its 
protective role in PE via this subunit by eliciting an anti-inflammatory response. 
Additionally, a change in α2 and β1 subunit expression was observed at the cellular level. 
This thesis proposes that the greater expression of α2 in smokers compared to PE may be 
occurring as a protective mechanism via an increase in ACh signaling whereby amino 
acid uptake is increased. Furthermore, it is possible that the increased expression of β1, 
purely via nicotine from cigarette smoke, is implicated in the increased calcification and 
apoptosis seen in placentas from smoking women (Jauniaux et al., 2007) via an increase 
in ion channel permeability and subsequent Ca2+ influx.   
 
Both exogenous regulation of placental nAChRs by cigarette smoke exposure and 
endogenous regulation, via ACh, are therefore likely to alter nAChR subunit expression, 
and ultimately function, in the human placenta, impacting on infant outcomes. When 
comparing the nAChR subunits between smoking and PE groups, the possibility of a 
protective mechanism becomes an apparent possibility whereby alterations in certain 
subunits as a result of PE, can be counteracted by either exogenously agonizing or 
antagonizing the same subunits to reverse the effects. Thus clinically, this study 
introduces the possibility of targeting the nAChR subunits via artificial nicotine 
mimetic(s) to elaborate protection against this pregnancy specific disease, a path worthy 
of further investigation. 
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